Performance of BCAB Bioatla Inc | -10.5% in 12m
Compare BCAB with Indices, Sectors and Commodities ✔ like Oil, Gas, Gold, Yields and Bonds. Who outperforms?
Compare Bioatla Inc with its related Sector/Index XBI
Performance Duell BCAB vs XBI
| TimeFrame | BCAB | XBI |
|---|---|---|
| 1 Day | -7.03% | -1.46% |
| 1 Week | -7.91% | 2.04% |
| 1 Month | -18.5% | -1.43% |
| 3 Months | 5.82% | -0.12% |
| 6 Months | 98.6% | 28.37% |
| 12 Months | -10.5% | 4.86% |
| YTD | 9.81% | -1.24% |
| Rel. Perf. 1m | -1.25 | |
| Rel. Perf. 3m | 2.65 | |
| Rel. Perf. 6m | 3.01 | |
| Rel. Perf. 12m | -1.35 |
Is Bioatla Inc a good stock to buy?
No, based on ValueRay Fundamental Analyses, Bioatla Inc (NASDAQ:BCAB) is currently (May 2024)
a stock to sell. It has a ValueRay Fundamental Rating of -89.99 and therefor a negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of BCAB as of May 2024 is 2.90. This means that BCAB is currently overvalued and has a potential downside of -7.35% (Sold with Premium).
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of BCAB as of May 2024 is 2.90. This means that BCAB is currently overvalued and has a potential downside of -7.35% (Sold with Premium).
Is BCAB a buy, sell or hold?
- Strong Buy: 2
- Buy: 3
- Hold: 0
- Sell: 0
- Strong Sell: 0
Values above 0%: BCAB is performing better - Values below 0%: BCAB is underperforming
Compare BCAB with Broad Market Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -11.28% | -18.20% | 79.50% | -37.58% |
| US NASDAQ 100 | QQQ | -12.31% | -18.37% | 80.18% | -47.32% |
| US Dow Jones Industrial 30 | DIA | -10.97% | -18.90% | 83.09% | -28.85% |
| German DAX 40 | DBXD | -11.20% | -19.26% | 77.55% | -25.87% |
| UK FTSE 100 | ISFU | -10.93% | -22.68% | 82.04% | -21.21% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -7.87% | -22.86% | 95.17% | 0.55% |
| Hongkong Hang Seng | HSI | -11.57% | -25.74% | 98.61% | 5.07% |
| Japan Nikkei 225 | EXX7 | -7.78% | -13.89% | 83.86% | -27.81% |
| India NIFTY 50 | INDA | -7.17% | -17.80% | 81.28% | -35.96% |
| Brasil Bovespa | EWZ | -11.92% | -18.12% | 93.72% | -30.41% |
BCAB Bioatla Inc vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -11.32% | -16.95% | 77.48% | -49.66% |
| Consumer Discretionary | XLY | -9.82% | -17.00% | 88.26% | -31.82% |
| Consumer Staples | XLP | -9.91% | -21.59% | 85.67% | -12.81% |
| Energy | XLE | -9.07% | -14.02% | 84.12% | -30.52% |
| Financial | XLF | -10.39% | -17.56% | 74.72% | -40.47% |
| Health Care | XLV | -8.98% | -18.01% | 86.88% | -18.80% |
| Industrial | XLI | -10.49% | -17.61% | 74.84% | -37.98% |
| Materials | XLB | -9.74% | -16.21% | 79.75% | -27.07% |
| Real Estate | XLRE | -10.29% | -14.25% | 89.43% | -13.72% |
| Technology | XLK | -13.36% | -17.83% | 81.64% | -47.07% |
| Utilities | XLU | -12.00% | -25.63% | 81.00% | -16.08% |
| Aerospace & Defense | XAR | -11.20% | -20.89% | 79.33% | -36.24% |
| Biotech | XBI | -9.95% | -17.06% | 70.26% | -15.32% |
| Homebuilder | XHB | -11.07% | -15.64% | 61.10% | -59.78% |
| Retail | XRT | -10.97% | -16.67% | 76.22% | -31.57% |
Does Bioatla Inc outperform its market, is BCAB a Sector Leader?
No, over the last 12 months Bioatla Inc (BCAB) made -10.46%, while its related Sector, the SPDR S&P Biotech (XBI) made 4.86%.
Over the last 3 months BCAB made 5.82%, while XBI made -0.12%.
No, over the last 12 months Bioatla Inc (BCAB) made -10.46%, while its related Sector, the SPDR S&P Biotech (XBI) made 4.86%.
Over the last 3 months BCAB made 5.82%, while XBI made -0.12%.
| Period | BCAB | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -18.49% | -1.43% | -0.29% |
| 3 Months | 5.82% | -0.12% | 4.11% |
| 12 Months | -10.46% | 4.86% | 27.12% |